|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pharmacology, University of South Alabama, Mobile, Alabama, United States; Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas, United States
2 Gynecology and Obstetrics, Stanford University Medical Center, Stanford, California, United States
3 Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas, United States
4 Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon, United States
* To whom correspondence should be addressed. E-mail: trich{at}jaguar1.usouthal.edu.
We have previously used cyclic nucleotide-gated (CNG) channels as sensors to measure cAMP signals in HEK-293 cells. We found that prostaglandin E1 (PGE1) triggered transient increases in cAMP concentration near the plasma membrane, whereas total cAMP levels rose to a steady plateau over the same time-course. In addition, we presented evidence that the decline in the near-membrane cAMP levels was due primarily to a PGE1-induced stimulation of PDE activity, and that the differences between near-membrane and total cAMP levels were largely due to diffusional barriers and differential PDE activity. Here, we examine the mechanisms of transient, near-membrane cAMP signals. We observed that 5 minute stimulation of HEK-293 cells with prostaglandins triggered a two- to three-fold increase in PDE4 activity. Extracellular application of H89 (a PKA inhibitor) inhibited stimulation of PDE4 activity. Similarly, when we used CNG channels to monitor cAMP signals we found that both extracellular and intracellular (via the whole-cell patch pipette) application of H89, or the highly-selective PKA inhibitor, PKI, prevented the decline in prostaglandin-induced responses. Following pretreatment with rolipram (a PDE4 inhibitor), H89 had little or no effect on near membrane or total cAMP levels. Furthermore, disrupting the subcellular localization of PKA with the A-kinase anchoring protein (AKAP) disruptor Ht31 prevented the decline in the transient response. Based upon these data we developed a plausible kinetic model that describes prostaglandin-induced cAMP signals. This model has allowed us to quantitatively demonstrate the importance of PKA-mediated stimulation of PDE4 activity in shaping near membrane cAMP signals.
This article has been cited by other articles:
![]() |
S. Togo, X. Liu, X. Wang, H. Sugiura, K. Kamio, S. Kawasaki, T. Kobayashi, R. F. Ertl, Y. Ahn, O. Holz, et al. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L959 - L969. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Adderley, E. A. Dufaux, M. Sridharan, E. A. Bowles, M. S. Hanson, A. H. Stephenson, M. L. Ellsworth, and R. S. Sprague Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1617 - H1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. De Arcangelis, D. Soto, and Y. Xiang Phosphodiesterase 4 and Phosphatase 2A Differentially Regulate cAMP/Protein Kinase A Signaling for Cardiac Myocyte Contraction under Stimulation of {beta}1 Adrenergic Receptor Mol. Pharmacol., November 1, 2008; 74(5): 1453 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, J. A. Enyeart, and J. J. Enyeart ACTH Inhibits bTREK-1 K+ Channels through Multiple cAMP-dependent Signaling Pathways J. Gen. Physiol., August 1, 2008; 132(2): 279 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xin, T. M. Tran, W. Richter, R. B. Clark, and T. C. Rich Roles of GRK and PDE4 Activities in the Regulation of {beta}2 Adrenergic Signaling J. Gen. Physiol., March 31, 2008; 131(4): 349 - 364. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |